Downregulation of receptor for activated C‐kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor‐associated angiogenesis

By behaving as molecular hubs, scaffold proteins can assemble a large number of signaling molecules and organize complicated intracellular signaling networks in time and space. Owing to their crucial role in mediating intracellular signaling related to tumor cell growth and migration, recent studies have highlighted the relevance of scaffold proteins in human cancers and indicated that interfering with their expression and/or their ability to bind effector proteins can inhibit cancer progression. Here, we show that receptor for activated C‐kinase 1 (RACK1), a ubiquitously expressed scaffolding protein, plays a crucial regulatory role in tumor growth. Using an RNA silencing approach, we found that downregulation of RACK1 expression in HeLa and A673 tumor cells markedly suppressed the proliferation and invasion of these cells in vitro and tumor development in vivo. Consequently, we found that significant suppression of constitutive phosphorylation of Akt and MAPK by RACK1 silencing may contribute to the inhibition of tumor growth. Moreover, RACK1 silencing significantly attenuated tumor‐associated angiogenesis by, at least in part, inhibiting the expression of two critical angiogenic factors, namely vascular endothelial growth factor‐B and fibroblast growth factor 2. The results of the present study show that RACK1 is a potent enhancer of tumor growth and, thus, a potential anti‐cancer therapeutic target. (Cancer Sci 2011; 102: 2007–2013)

[1]  M. Shibuya,et al.  RACK1 Regulates VEGF/Flt1-mediated Cell Migration via Activation of a PI3K/Akt Pathway* , 2011, The Journal of Biological Chemistry.

[2]  K. Alitalo,et al.  Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis , 2010, PloS one.

[3]  D. Ron,et al.  Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1* , 2010, The Journal of Biological Chemistry.

[4]  M. Falasca PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. , 2010, Current pharmaceutical design.

[5]  D. Sacks,et al.  IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis , 2009, FEBS letters.

[6]  N. Gotoh,et al.  The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment , 2009, Expert opinion on therapeutic targets.

[7]  Katia Bourd-Boittin,et al.  RACK1, a New ADAM12 Interacting Protein , 2008, Journal of Biological Chemistry.

[8]  X. Sastre-Garau,et al.  Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation , 2008, Molecular Cancer.

[9]  Ido Amit,et al.  Regulation of MAPKs by growth factors and receptor tyrosine kinases. , 2007, Biochimica et biophysica acta.

[10]  L. Miller,et al.  RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints , 2007, Oncogene.

[11]  Yihai Cao,et al.  Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. , 2007, Advances in cancer research.

[12]  J. Folkman Angiogenesis: an organizing principle for drug discovery? , 2007, Nature reviews. Drug discovery.

[13]  A. Griffioen,et al.  Monocyte/macrophage infiltration in tumors: modulators of angiogenesis , 2006, Journal of leukocyte biology.

[14]  T. Vomastek,et al.  Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. , 2006, Cancer research.

[15]  H. Schnaper,et al.  RACK1 Binds to Smad3 to Modulate Transforming Growth Factor-β1-stimulated α2(I) Collagen Transcription in Renal Tubular Epithelial Cells* , 2006, Journal of Biological Chemistry.

[16]  Paola Defilippi,et al.  p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.

[17]  Z. Ronai,et al.  RACK1 Recruits STAT3 Specifically to Insulin and Insulin-Like Growth Factor 1 Receptors for Activation, Which Is Important for Regulating Anchorage-Independent Growth , 2006, Molecular and Cellular Biology.

[18]  H. Schnaper,et al.  RACK1 binds to Smad3 to modulate transforming growth factor-beta1-stimulated alpha2(I) collagen transcription in renal tubular epithelial cells. , 2006, The Journal of biological chemistry.

[19]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[20]  G. Kay,et al.  Transgenic Overexpression of Vascular Endothelial Growth Factor-B Isoforms by Endothelial Cells Potentiates Postnatal Vessel Growth In Vivo and In Vitro , 2005, Circulation research.

[21]  M. Lisanti,et al.  Caveolin in breast cancer , 2004 .

[22]  M. Lisanti,et al.  Caveolin-1 in breast cancer. , 2004, Cancer biology & therapy.

[23]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[24]  J. Warwicker,et al.  The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. , 2002, Molecular pharmacology.

[25]  R. O'Connor,et al.  RACK1 Is an Insulin-like Growth Factor 1 (IGF-1) Receptor-interacting Protein That Can Regulate IGF-1-mediated Akt Activation and Protection from Cell Death* , 2002, The Journal of Biological Chemistry.

[26]  V. Yong,et al.  The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. , 2002, The Journal of biological chemistry.

[27]  A. Tanigami,et al.  Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. , 2002, Cancer letters.

[28]  Weiqun Li,et al.  RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix , 2002, Molecular and Cellular Biology.

[29]  Daria Mochly-Rosen,et al.  Adaptor proteins in protein kinase C-mediated signal transduction , 2001, Oncogene.

[30]  C. Cartwright,et al.  The Interaction of Src and RACK1 Is Enhanced by Activation of Protein Kinase C and Tyrosine Phosphorylation of RACK1* , 2001, The Journal of Biological Chemistry.

[31]  B. Hengerer,et al.  RACK1 IS UP‐REGULATED IN ANGIOGENESIS AND HUMAN CARCINOMAS , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[33]  M. Houslay,et al.  The RACK1 Signaling Scaffold Protein Selectively Interacts with the cAMP-specific Phosphodiesterase PDE4D5 Isoform* , 1999, The Journal of Biological Chemistry.

[34]  A. Harris,et al.  Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast , 1999, British Journal of Cancer.

[35]  D. Chang,et al.  Rack1, a Receptor for Activated Protein Kinase C, Interacts with Integrin β Subunit* , 1998, The Journal of Biological Chemistry.

[36]  D. Mochly‐Rosen,et al.  Agonists and antagonists of protein kinase C function, derived from its binding proteins. , 1994, The Journal of biological chemistry.

[37]  J. Caldwell,et al.  Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.